Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2006-04-01 (20 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: PARIS (75009), Paris
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DE LA TRINITE : revenue, balance sheet and financial ratios
PHARMACIE DE LA TRINITE is a French company
founded 20 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in PARIS (75009),
this company of category PME
shows in 2022 a revenue of 1.7 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE LA TRINITE (SIREN 489423467)
Indicator
2024
2023
2022
2021
2020
2018
2017
2016
Revenue
N/C
N/C
1 665 408 €
N/C
N/C
N/C
N/C
N/C
Net income
-195 053 €
-171 689 €
1 246 112 €
258 023 €
191 253 €
132 489 €
244 924 €
109 431 €
EBITDA
N/C
N/C
31 516 €
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
74.8%
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, PHARMACIE DE LA TRINITE records a net loss of 195 k€. This deficit will reduce equity on the balance sheet.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
-195 053 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at -456%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches -18%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
-456.26%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
-17.979%
Solvency indicators evolution PHARMACIE DE LA TRINITE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2020
2021
2022
2023
2024
Debt ratio
12.931
16.141
19.173
47.025
16.068
20.16
3.928
-456.26
Financial autonomy
40.706
49.15
47.044
49.148
55.655
68.076
73.858
-17.979
Repayment capacity
None
None
None
None
None
6.213
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
1.6%
None%
None%
Sector positioning
Debt ratio
-456.262024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Excellent
In 2024, the debt ratio of PHARMACIE DE LA TRINITE (-456.26) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
-17.98%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Watch-54 pts over 3 years
In 2024, the financial autonomy of PHARMACIE DE LA TRINITE (-18.0%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.
Repayment capacity
6.21 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Average
In 2022, the repayment capacity of PHARMACIE DE LA TRINITE (6.21) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DE LA TRINITE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2020
2021
2022
2023
2024
Operating WCR
0 €
0 €
0 €
0 €
0 €
465 232 €
0 €
0 €
Inventory turnover (days)
0
0
0
0
0
37
0
0
Customer payment term (days)
0
0
0
0
0
38
0
0
Supplier payment term (days)
0
0
0
0
0
31
0
0
Positioning of PHARMACIE DE LA TRINITE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE LA TRINITE with other companies in the same sector:
Frequently asked questions about PHARMACIE DE LA TRINITE
What is the revenue of PHARMACIE DE LA TRINITE ?
The revenue of PHARMACIE DE LA TRINITE in 2022 is 1.7 M€.
Is PHARMACIE DE LA TRINITE profitable?
PHARMACIE DE LA TRINITE recorded a net loss in 2024.
Where is the headquarters of PHARMACIE DE LA TRINITE ?
The headquarters of PHARMACIE DE LA TRINITE is located in PARIS (75009), in the department Paris.
Where to find the tax return of PHARMACIE DE LA TRINITE ?
The tax return of PHARMACIE DE LA TRINITE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE LA TRINITE operate?
PHARMACIE DE LA TRINITE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart